Rockefeller Capital Management’s Meridian Bioscience Inc VIVO Stock Holding History

Rockefeller Capital Management’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-2,018	Closed	-$67K	–	4214
2022 Q4	$67K	Hold	2,018	–	–	﹤0.01%	2240
2022 Q3	$63K	Sell	2,018 -87	-4%	-$2.82K	﹤0.01%	2232
2022 Q2	$64K	Buy	2,105 +105	+5%	+$2.84K	﹤0.01%	2179
2022 Q1	$51K	Hold	2,000	–	–	﹤0.01%	2297
2021 Q4	$40K	Hold	2,000	–	–	﹤0.01%	2322
2021 Q3	$38K	Hold	2,000	–	–	﹤0.01%	2280
2021 Q2	$44K	Buy	+2,000	New	+$42.4K	﹤0.01%	2144
2019 Q2	–	Sell	-280	Closed	-$5K	–	2058
2019 Q1	$5K	Buy	+280	New	+$4.66K	﹤0.01%	1645

Other funds holding VIVO

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Rockefeller Capital Management's VIVO Position: Q1 2023 in Review

Rockefeller Capital Management sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 2,018 shares — an estimated $67K sold.

Rockefeller Capital Management first reported a position in VIVO in Q1 2019 and held it in 8 quarters. The position peaked at $67K in Q4 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

Rockefeller Capital Management reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
Rockefeller Capital Management sold 2,018 Meridian Bioscience Inc shares in Q1 2023, an estimated $67K.
Rockefeller Capital Management first reported a position in Meridian Bioscience Inc in Q1 2019 and held it in 8 quarters.
Rockefeller Capital Management's Meridian Bioscience Inc position peaked at $67K in Q4 2022.
2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Rockefeller Capital Management's 13F filing for Q1 2023, filed 16 May 2023.